The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)The Environmental Protection Department of the National Development and Reform Commission organized the liaison meeting of the coordination mechanism of cleaner production promotion departments in 2024. On the afternoon of December 10th, the Environmental Protection Department of the National Development and Reform Commission organized the liaison meeting of the coordination mechanism of cleaner production promotion departments in 2024 to sort out and summarize the latest progress, existing problems and difficulties in the implementation of cleaner production in 2024, study the key tasks in 2025, and promote the completion of the objectives and tasks of the Tenth Five-Year Plan.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)
On the 12th, South Korea's National Assembly voted to pass a special civil strife inspection law to investigate President Yin Xiyue's suspicion of civil strife. (Xinhua News Agency)Ai Kelan: The actual controller intends to transfer 5% shares of the company by agreement. Ai Kelan announced that Liu Yi, the controlling shareholder and actual controller of the company, intends to transfer 4 million unrestricted shares of the company to Guangdong Nanchuan Private Equity Fund Management Co., Ltd. by agreement transfer, accounting for 5.00% of the company's total share capital. If the transaction is finally completed, Liu Yi holds 33.89% of the company's shares, and Nanchuan Private Equity holds 5.00% of the company's shares. This change in equity will not lead to changes in the controlling shareholder and actual controller of the company. The transfer of shares in this agreement can only be handled in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. after the compliance confirmation of Shenzhen Stock Exchange. The share transfer price of this transaction is 20.61 yuan/share.The State Council approved the Hefei Land and Space Master Plan (2021-2035), which proposed to improve the functional structure and spatial layout of the city, coordinate the industrial layout, comprehensive transportation, facility allocation and land use, and give priority to ensuring the space needs of advanced manufacturing industries, scientific apparatus and other scientific and technological innovations. Build an international air cargo hub and a national railway hub, improve the service level of logistics infrastructure, improve the external and internal channels of multi-directional Unicom and multimodal transport, and build a safe, convenient, green and low-carbon urban comprehensive transportation system. Coordinate water conservancy, energy, environment, communications, national defense and other infrastructure spaces, actively and steadily promote the construction of "flat and emergency dual-use" public infrastructure, optimize the regional layout of disaster prevention, mitigation and relief facilities, and improve the security and resilience of national space.
Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.LambdaTest received $38 million in financing, and Qualcomm Venture Capital participated in the investment. On December 12th, LambdaTest, a unified cloud testing platform, announced that the company had received $38 million in financing led by Avataar Ventures and invested by Qualcomm Venture Capital, with a total financing amount of $108 million. Founded in 2017, LambdaTest has raised nearly $70 million from investors in previous rounds of financing, including Premji Invest, Sequoia Capital India, Titanium Ventures, Leo Capital Holdings and Blume Ventures.Weilai Li Bin: R&D investment is in basic research. Weilai's R&D expenses for Le Dao are far less than Xiaomi's R&D expenses for Xiaomi Automobile. (Sina Technology)
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13